US Bancorp’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.3K | Sell |
504
-135
| -21% | -$18.6K | ﹤0.01% | 2624 |
|
|
2025
Q1 | $115K | Sell |
639
-388
| -38% | -$70K | ﹤0.01% | 2328 |
|
|
2024
Q4 | $161K | Buy |
1,027
+82
| +9% | +$12.8K | ﹤0.01% | 2132 |
|
|
2024
Q3 | $172K | Sell |
945
-818
| -46% | -$149K | ﹤0.01% | 2105 |
|
|
2024
Q2 | $324K | Sell |
1,763
-34
| -2% | -$6.24K | ﹤0.01% | 1752 |
|
|
2024
Q1 | $320K | Buy |
1,797
+173
| +11% | +$30.8K | ﹤0.01% | 1770 |
|
|
2023
Q4 | $201K | Buy |
1,624
+1,435
| +759% | +$178K | ﹤0.01% | 2005 |
|
|
2023
Q3 | $21.9K | Hold |
189
| – | – | ﹤0.01% | 2829 |
|
|
2023
Q2 | $22.2K | Buy |
189
+10
| +6% | +$1.17K | ﹤0.01% | 2900 |
|
|
2023
Q1 | $14.3K | Sell |
179
-13
| -7% | -$1.04K | ﹤0.01% | 3141 |
|
|
2022
Q4 | $15.2K | Sell |
192
-48
| -20% | -$3.8K | ﹤0.01% | 3125 |
|
|
2022
Q3 | $17K | Sell |
240
-166
| -41% | -$11.8K | ﹤0.01% | 3096 |
|
|
2022
Q2 | $27K | Sell |
406
-265
| -39% | -$17.6K | ﹤0.01% | 2882 |
|
|
2022
Q1 | $45K | Sell |
671
-164
| -20% | -$11K | ﹤0.01% | 2674 |
|
|
2021
Q4 | $58K | Buy |
835
+725
| +659% | +$50.4K | ﹤0.01% | 2562 |
|
|
2021
Q3 | $6K | Buy |
110
+16
| +17% | +$873 | ﹤0.01% | 3560 |
|
|
2021
Q2 | $6K | Sell |
94
-111
| -54% | -$7.09K | ﹤0.01% | 3543 |
|
|
2021
Q1 | $16K | Hold |
205
| – | – | ﹤0.01% | 3108 |
|
|
2020
Q4 | $12K | Hold |
205
| – | – | ﹤0.01% | 3090 |
|
|
2020
Q3 | $9K | Hold |
205
| – | – | ﹤0.01% | 3064 |
|
|
2020
Q2 | $8K | Buy |
+205
| New | +$8K | ﹤0.01% | 3095 |
|